Journal of Clinical Medicine of Kazakhstan
Online ISSN:
2313-1519
Print ISSN:
1812-2892
Journal of Clinical Medicine of Kazakhstan
HOME PAGE
ISSUES
CURRENT ISSUE
ARTICLES IN PRESS
ARCHIVE
ABOUT JOURNAL
Aims and Scope
Peer Review Process
Open Access Policy
Copyright and Permissions
Advertising and Marketing Policy
Archiving Policy
Indexing Information
Publisher Information
Journal History
ICJME Recommendations
COPE Guidelines
FOR AUTHORS
Instructions for Authors
Peer Review Policy
Publication Ethics
Research Ethics Policy
Corrections Retractions and Concerns
Article processing charges
Reporting Guidelines
Forms
EDITORIAL OFFICE
Governing Body
Editorial Board
Advisory Board
CONTACT
Online Submission System
Keyword:
resveratrol
Search Results (3)
Hematological dynamics following the co-administration of Resveratrol and Cisplatin in Sprague–Dawley rats.
Гематологические параметры у крыс Спрег-Доули после введения ресвератрола и цисплатина
Izuchukwu Azuka Okafor, Johnson Okwudili Nweke, Uchenna Somtochukwu Nnamah
J CLIN MED KAZ 2018; 2(48):22-27
DOI:
https://doi.org/10.23950/1812-2892-JCMK-00563
[PDF]
Influence of resveratrol on the structural and functional state of the thyroid gland in patients with autoimmune thyroiditis combined with stable ischemic heart disease
Влияние ресвератрола на структурно-функциональное состояние щитовидной железы у больных аутоиммунным тиреоидитом в сочетании со стабильной ишемической болезнью сердца
Natalya Chekalina
J CLIN MED KAZ 2017; 1(43):48-55
DOI:
https://doi.org/10.23950/1812-2892-JCMK-00443
[PDF]
Resveratrol reduces the inflammatory activation of endothelum in patients with coronary heart disease combined with autoimmune thyroiditis
Ресвератрол снижает воспалительную активацию эндотелия у больных ишемической болезнью сердца в сочетании с аутоиммунным тиреоидитом
Natalia Chekalina
J CLIN MED KAZ 2016; 3(41):21-26
DOI:
https://doi.org/10.23950/1812-2892-2016-3-21-26
[PDF]
Current Issue
Volume 21, Number 5 (2024)
Previous Issues
Articles in Press
This journal is licensed under the CC-BY Creative Commons Attribution 4.0 International License.